ICYMI: Voter priorities this election season
PhRMA Blog
by
2d ago
Political posturing during the 2024 election season is injecting partisan politics into health care debates ..read more
Visit website
New study finds insurers and PBMs increasing access restrictions in Medicare Part D
PhRMA Blog
by
2d ago
Medicare beneficiaries are facing greater access restrictions on their lifesaving medicines ..read more
Visit website
Government price setting won’t help patients in Illinois
PhRMA Blog
by
2d ago
While Illinois lawmakers consider a “Health Care Availability and Access Board” (sometimes referred to as a prescription drug affordability board or PDAB), these boards are really code for government price-setting. Illinoisans should be concerned ..read more
Visit website
Insurance data: PBM reform has no material impact on premiums
PhRMA Blog
by
2d ago
A first-of-its-kind analysis found no evidence a new law requiring insurance companies and their pharmacy benefit managers (PBM) to share rebates with patients has an impact on premiums ..read more
Visit website
IRA is already negatively impacting access to medicines in Part D
PhRMA Blog
by
2d ago
Policy experts, providers and others have warned that Part D plans will likely restrict patient access to medicines because of the price setting and other provisions in the IRA ..read more
Visit website
Why won’t USTR strengthen medical supply chains with America’s allies?
PhRMA Blog
by
2d ago
Despite USTR’s misguided views, further enhancing the resilience of U.S. supply chains cannot be achieved absent an ambitious, pro-innovation trade agenda ..read more
Visit website
World IP Day 2024: Supporting an innovative and sustainable future
PhRMA Blog
by
2d ago
Biopharmaceutical research, development and manufacturing relies on the global IP and innovation ecosystem to enable risk-taking and collaboration on a massive scale ..read more
Visit website
What recent rhetoric on the cost of diabetes and anti-obesity medicines gets wrong
PhRMA Blog
by
1w ago
A new activist-funded study published in JAMA is fueling misleading rhetoric around the cost of diabetes and anti-obesity medicines ..read more
Visit website
New analysis: Flawed assessments of a medicine’s value jeopardize patient access
PhRMA Blog
by
1w ago
The Inflation Reduction Act already threatens seniors’ access to care. Injecting ICER’s flawed value assessments to an already flawed government decision making about drug payment could further jeopardize patients’ ability to get the lifesaving treatments they need ..read more
Visit website
The impact of innovative medicines: A caregiver's perspective
PhRMA Blog
by
3w ago
As someone who has had family members impacted by serious illness, I know that biopharmaceutical progress in recent decades has improved patient outcomes immensely, helping people enjoy healthier, more fulfilling lives ..read more
Visit website

Follow PhRMA Blog on FeedSpot

Continue with Google
Continue with Apple
OR